Overview
Cellectricon provides customized in vitro neurobiology services for pharmaceutical drug discovery, focusing on areas like neurotoxicity, neuroinflammation, neurodegeneration, and neuroplasticity. They utilize proprietary technologies such as Cellaxess® for cell engineering and selective stimulation, and Dynaflow® for ion channel research, alongside advanced assays integrating optical electrophysiology and high-content imaging. These services support early target identification, lead optimization, and safety assessment using physiologically relevant cell and tissue models.
Frequently asked questions
- What core services does Cellectricon offer for pharma R&D?
- Cellectricon offers customized in vitro neurobiology services including neurotoxicity testing, neuroinflammation models, neurodegeneration assays, and neuroplasticity screening to accelerate early drug discovery programs.
- What proprietary technologies does Cellectricon use?
- Key technologies include Cellaxess® for high-resolution ion-channel screening, cell engineering, and selective field stimulation of excitable cells, plus Dynaflow® for ion channel research and discovery applications.
- What therapeutic areas and models does Cellectricon specialize in?
- Specialties cover peripheral neuropathies, neuroinflammation, neurodegeneration, and neuroplasticity, using advanced in vitro models with primary cells, stem cells, optical electrophysiology, high-content imaging, and microfluidic systems.